The UC Davis Comprehensive Cancer Center achieved NCI designation in July,
2002 based on six scientific programs in molecular oncology, cancer biology
in animals, therapeutics (both developmental and experimental), cancer
etiology, prevention, and control, prostate cancer, and biomedical technology.
The only designated center between San Francisco and the Oregon border,
the center provides tertiary care to a population of about five million;
some 2,200 newly diagnosed cancer patients are seen annually (UC Davis
Health System Registry). Approximately 180 members are found across the
University of California, Davis including the School of Medicine, the
School of Veterinary Medicine, the College of Agricultural and Environmental
Sciences, the Division of Biological Sciences, and the College of Engineering,
and at the Lawrence Livermore National Laboratory in Livermore, California;
scientists at the Laboratory collaborate with UC Davis investigators
through a formal Memorandum of Understanding signed between the two institutions.
Areas of keen interest include DNA repair, signal transduction
and tyrosine kinases, therapeutics for companion animal cancers, mouse
models, combinatorial chemistry and targeted therapy, correlative studies,
androgen independence in prostate cancer, dietary induction of cancer,
cancer health disparities, applications of biophotonics to cancer detection
and treatment, human and animal imaging of cancer in vivo, novel drug
delivery systems using nanoparticles, bioinformatics, and new research
technologies such as accelerator mass spectrometry and atomic force microscopy.
|
